Aggrastat (Tirofiban Hydrochloride Monohydrate)

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain medical procedures to reduce the risk of clot formation.

Aggrastat is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI) or those with acute coronary syndrome. It works by inhibiting platelet aggregation, which helps to keep blood flowing smoothly through the arteries. This medication is often used in hospital settings under medical supervision.

Common effects of Aggrastat may include bleeding, bruising, and prolonged bleeding from cuts or injuries. Some patients may also experience nausea, dizziness, or headache. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

Aggrastat should be handled with care, as it can increase the risk of bleeding. Patients with a history of bleeding disorders, recent surgery, or severe hypertension should use this medication with caution. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be avoided while using this medication.